138 related articles for article (PubMed ID: 10568224)
61. [Effect of calcitriol, a vitamin D compound, in bone disease associated with distal renal tubular acidosis].
Radó J; Pató E; Haris A; Balogh I
Orv Hetil; 1994 Oct; 135(42):2319-23. PubMed ID: 7970647
[TBL] [Abstract][Full Text] [Related]
62. The Effect of Alendronate on Bone Mineral Disorder in Renal Transplant Patients.
Uçar ZA; Sinangil A; Koç Y; Barlas IS; Ecder ST; Akin EB
Transplant Proc; 2022 Apr; 54(3):658-662. PubMed ID: 35272880
[TBL] [Abstract][Full Text] [Related]
63. Calcium and calcitriol therapy in osteoporotic postmenopausal women with impaired calcium absorption.
Need AG; Nordin C; Horowitz M; Morris HA
Metabolism; 1990 Apr; 39(4 Suppl 1):53-4. PubMed ID: 2325573
[TBL] [Abstract][Full Text] [Related]
64. Long-term treatment with calcitriol in postmenopausal osteoporosis.
Caniggia A; Nuti R; Lore F; Martini G; Turchetti V; Righi G
Metabolism; 1990 Apr; 39(4 Suppl 1):43-9. PubMed ID: 2325571
[TBL] [Abstract][Full Text] [Related]
65. [Effects of calcitriol and alfacalcidol on an osteoporosis model in rats with hepatic failure].
Yamanishi A; Ishibashi Y; Kuriyama K; Tachiiri T; Kusajima H; Kojima E; Momo K
Nihon Yakurigaku Zasshi; 1999 Jan; 113(1):55-65. PubMed ID: 10096106
[TBL] [Abstract][Full Text] [Related]
66. Calcium, vitamin D supplements with or without alendronate and supragingival calculus formation in osteoporotic women: a preliminary study.
Buduneli N; Saygan BH; Karaduman U; Saraç F; Karaduman M; Ayçelik N
Expert Opin Pharmacother; 2008 Aug; 9(12):2015-20. PubMed ID: 18671457
[TBL] [Abstract][Full Text] [Related]
67. [The effect of 1,25-dihydroxycholecalciferol on immunity and the clinical state and on parameters of phospho-calcium metabolism in dialyzed patients].
Bartůnková J; Sulková S; Fucíková T; Marecková H; Válek A
Cas Lek Cesk; 1990 Aug; 129(35):1102-6. PubMed ID: 2121362
[TBL] [Abstract][Full Text] [Related]
68. Calcitriol in the treatment of postmenopausal osteoporosis.
Aloia JF; Vaswani A; Yeh JK; Ellis K; Yasumura S; Cohn SH
Am J Med; 1988 Mar; 84(3 Pt 1):401-8. PubMed ID: 3279769
[TBL] [Abstract][Full Text] [Related]
69. Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation.
Cueto-Manzano AM; Konel S; Freemont AJ; Adams JE; Mawer B; Gokal R; Hutchison AJ
Am J Kidney Dis; 2000 Feb; 35(2):227-36. PubMed ID: 10676721
[TBL] [Abstract][Full Text] [Related]
70. Low-dose calcitriol versus calcium in established postmenopausal osteoporosis.
Tilyard M
Metabolism; 1990 Apr; 39(4 Suppl 1):50-2. PubMed ID: 2325572
[TBL] [Abstract][Full Text] [Related]
71. Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis.
Gallagher JC
Metabolism; 1990 Apr; 39(4 Suppl 1):27-9. PubMed ID: 2325568
[TBL] [Abstract][Full Text] [Related]
72. The efficacy and safety of a combined alendronate and calcitriol agent (maxmarvil): a postmarketing surveillance study in korean postmenopausal women with osteoporosis.
Suh HW; Kim HO; Kim YS; Sunwoo S; Lee JA; Lee HR; Kim B; Kim DH; Choi YS; Cheong YS; Yum K; Yang YJ; Yu BY; Cho CH; Park SB; Shin DH;
Korean J Fam Med; 2012 Nov; 33(6):346-55. PubMed ID: 23267420
[TBL] [Abstract][Full Text] [Related]
73. 1,25-Dihydroxyvitamin D3 receptors in peripheral blood mononuclear cells from patients with postmenopausal osteoporosis.
Martínez J; Olmos JM; Amado JA; Riancho JA; Freijanes J; González-Macías J
Bone Miner; 1993 Dec; 23(3):207-12. PubMed ID: 8148665
[TBL] [Abstract][Full Text] [Related]
74. Calcitriol or calcium for postmenopausal osteoporosis.
Fournier A; Sebert JL
N Engl J Med; 1992 Jul; 327(4):284. PubMed ID: 1614482
[No Abstract] [Full Text] [Related]
75. Treatment with hydrochlorothiazide and alendronate in patients with stones and bone mineral density loss. Evolution of bone metabolism and calciuria with medical treatment.
Arrabal-Martín M; González-Torres S; Cano-García MC; Poyatos-Andújar A; Abad-Menor F; Arrabal-Polo MA
Arch Esp Urol; 2016; 69(1):9-18. PubMed ID: 26856738
[TBL] [Abstract][Full Text] [Related]
76. [Changes in maturation index and vaginal dryness in postmenopausal women who use or not calcitriol].
Carranza-Lira S; Amador-Pérez C; Macgregor-Gooch AL; Estrada-Moscoso I
Rev Med Inst Mex Seguro Soc; 2012; 50(5):537-40. PubMed ID: 23282268
[TBL] [Abstract][Full Text] [Related]
77. Effect of calcitriol and pamidronate in multiple myeloma.
Imseis RE; Palmieri GM; Holbert JM; Leventhal MR; Sebes JI
Am J Med Sci; 1999 Jul; 318(1):61-6. PubMed ID: 10408763
[TBL] [Abstract][Full Text] [Related]
78. Posttransplant bone disease: a case illustrating dramatic improvements in bone density with vitamin D replacement therapy.
Dhingra RK; Sprague SM; Ojo AO; Leavey SF
Transplantation; 2001 Jun; 71(12):1856-9. PubMed ID: 11455270
[TBL] [Abstract][Full Text] [Related]
79. Reduced calcitriol requirements for treating hypoparathyroidism during lactation. A case report.
Caplan RH; Wickus GG
J Reprod Med; 1993 Nov; 38(11):914-8. PubMed ID: 8277494
[TBL] [Abstract][Full Text] [Related]
80. Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol.
Neer M; Slovik DM; Daly M; Potts T; Nussbaum SR
Osteoporos Int; 1993; 3 Suppl 1():204-5. PubMed ID: 8461561
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
